{{Rsnum
|rsid=892086
|Gene=DNM2
|Chromosome=19
|position=10727001
|Orientation=minus
|GMAF=0.4743
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=DNM2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 21.2 | 45.1 | 33.6
| HCB | 35.0 | 51.1 | 13.9
| JPT | 31.0 | 58.4 | 10.6
| YRI | 10.9 | 49.0 | 40.1
| ASW | 12.3 | 45.6 | 42.1
| CHB | 35.0 | 51.1 | 13.9
| CHD | 28.4 | 49.5 | 22.0
| GIH | 16.8 | 50.5 | 32.7
| LWK | 12.7 | 59.1 | 28.2
| MEX | 12.1 | 48.3 | 39.7
| MKK | 21.2 | 52.6 | 26.3
| TSI | 30.4 | 53.9 | 15.7
| HapMapRevision=28
}}Carriers with late-onset [[Alzheimer's disease]] who have [[rs892086]](T;T) genotypes appear to have less [[DNM2]] mRNA in their brains, according to a study of 429 Japanese patients, and among non-[[ApoE4]] carriers, appear to be at increased risk for developing [[Alzheimer's disease]]. The odds ratio reported is 1.53 (CI: 1.08-2.17, p=0.015).{{PMID|18236001}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}